查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138272

2022-2029 年全球血液学市场

Global Hematology Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

推动市场增长的主要因素是血液疾病患病率的上升、技术进步（例如引进新技术先进的全自动血液分析仪）以及研发成本的上升。

血液分析仪的技术进步有望推动市场增长。

贫血和缺铁仍然是世界上最常见的营养问题，影响着发达国家和发展中国家的数十亿人。通常使用各种标誌物来诊断贫血，例如红细胞计数、血细胞比容和总血红蛋白。现代血细胞计数器还可以测量红细胞特征，例如平均红细胞体积 (MCV) 和平均红细胞血红蛋白 (MCH)。但目前市售的许多分析仪价格昂贵，安装空间大，重量大，限制了可以使用的实验室数量，延迟了结果的传递，也有弱点的缺点。因此，需要一种可现场使用的便携式、廉价的血液分析仪。细胞追踪测速 (CTV) 是一种已知的技术，用于量化来自健康供体或镰状细胞病患者的新鲜人体血液的许多血液学参数。

此外，基于含有脱氧血红蛋白和高铁血红蛋白的红细胞在施加磁场后漂浮在水中时的顺磁性行为，我们结合磁体和微通道在短时间内产生数千个红细胞。跟踪红细胞的运动。这使得不仅可以测量传统的红细胞指标，还可以测量只有通过逐个细胞检查红细胞的分析仪才能获得的独特指标。此外，通过使用 CTV 作为血液分析仪，MCV、MCH、平均体积血红蛋白浓度 (MCHC)、红细胞分布宽度 (RDW)、色素减退细胞百分比（反映近期铁耗竭、骨髓铁短缺指标），并且可以测量这些指标之间的相关係数。因此，CTV 是一种很有前途的技术，可用于床旁和资源匮乏地区的血液检测。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

约束

由于产品召回导致技术采用延迟，以及对监管和报销的担忧将在预测期内抑制市场。

行业分析

血液学市场根据波特五力、供应链、定价分析和监管批准等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对市场产生了适度的影响。在全球范围内，用于测量 COVID-19 的血液学标准变得越来越重要。许多医院正在使用血液分析仪等工具对 COVID-19 患者进行检测和监测。临床血液学实验室对于提供各种有价值的预后标誌物至关重要，例如淋巴细胞减少症、中性粒细胞减少症、白细胞增多症和血小板减少症，这些都是 SARS-CoV-2 病毒患者的典型发现。此外，患有 COVID-19 和镰状细胞病 (SCD) 的患者住院、肺炎和不适的风险增加。 SCD 患者更容易受到感染，因此了解他们的健康状况非常重要，这对市场产生了重大影响。由于 COVID-19 患者血液学检测的重要性增加，预计对血液学产品和试剂的需求将会增加。与此同时，大流行正在扰乱供应链。因此，COVID-19 大流行正在影响市场。然而，这种情况预计在预测期内将稳步改善。

全球血液学市场报告提供大约 45 多个市场数据表、40 多个图表和 180 页内容。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 预计血液分析仪的技术进步将推动市场增长。
    • 限制
      • 在预测期内，监管和报销方面的问题预计会受到影响。
    • 市场机会
    • 影响分析

第五章行业分析

  • 波特的五种力量
  • 未满足的需求
  • 供应链
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 血液分析仪
  • 流式细胞仪
  • 凝血分析仪
  • 载玻片染色机
  • 离心机
  • 血红蛋白计
  • 其他

第 8 章试剂类型

  • 凝血试剂
  • 流式细胞仪试剂
  • 免疫血液学试剂
  • 其他

第 9 章。按应用程序

  • 药物测试
  • 自身免疫性疾病
  • 癌症
  • 糖尿病
  • 感染
  • 其他

第 10 章，最终用户

  • 医院
  • 实验室
  • 患者自我检查
  • 诊断中心
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 竞争场景
  • 竞争性血液学策略分析
  • 产品组合比较分析
  • 市场情况/份额分析
  • 併购分析

第 13 章公司简介

  • 雅培实验室
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Sysmex Corporation
  • Danaher Corporation
  • Siemens Healthcare
  • Sigma Aldrich Corporation
  • Drucker Diagnostics
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Mindray Medical International Ltd
  • Horiba Ltd

第14章 全球血液学市场-DataM

简介目录
Product Code: DMMD409

Market Overview

The global hematology market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

Hematology is a branch of medicine that deals with diagnosing, treating, and preventing blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological tests constitute in vitro diagnostic techniques such as hemostasis, molecular diagnostics, histology, blood analysis, and flow cytometry and help to identify various blood-related diseases at lower costs. Hematology includes the problems with the red blood cells, white blood cells, platelets, and organs fed by blood cells, including the lymph nodes, spleen, thymus, and lymphoid tissue. The specialists use the hematology instruments for testing and determining plasma drug levels for both therapeutic and illicit drugs.

Market Dynamics

The major drivers fueling the growth of the market are a rise in the prevalence of blood disorders, technological advancements such as the introduction of new technically advanced fully automated hematology analyzers, and rising R&D expenditure.

Technological advancements in hematological analyzers are expected to drive market growth.

Anemia and iron deficiency remain the most common nutritional problems in the world, impacting billions of people in industrialized and developing countries. Anemia is often diagnosed using various markers, including red blood cell (RBC) count, hematocrit, and total hemoglobin. Erythrocyte characteristics such as mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and so on are also measured using current hematology analyzers. However, most commercially available analyzers have several drawbacks as they are expensive instruments that require significant bench space and are heavy enough to limit their use to a specific lab and result in a delay in results, making them less practical as a point-of-care instrument that can be used for rapid clinical evaluation. As a result, there is a need for a portable and affordable hematological analyzer that can be used on the spot. A technique known as cell tracking velocimetry (CTV) is to quantify many hematological parameters from fresh human blood taken from healthy donors and sickle cell disease patients.

Moreover, based on the paramagnetic behavior of RBCs containing deoxyhemoglobin or methemoglobin while suspended in the water after applying a magnetic field, this system employs a combination of magnets and microfluidics to follow the movement of thousands of red cells in a short amount of time. This enables the measurement of not just traditional RBC indices but also unique metrics that are only available for analyzers that examine erythrocytes on a cell-by-cell basis. Additionally, the use of CTV as a hematology analyzer can measure MCV, MCH, mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), the percentage of hypochromic cells (which is an indicator of insufficient marrow iron supply that reflects recent iron reduction), and the correlation coefficients between these metrics. Therefore, CTV is a promising technology for blood testing at the point of care or in low-resource areas. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

Product recalls slow technology adoption and regulatory and reimbursement concerns are going to restrain the market in the forecast period.

Industry Analysis

The hematology market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis, regulatory approvals etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. Globally, there is a greater emphasis on hematological criteria for measuring COVID-19. Many hospitals have tested and monitored COVID-19 patients using tools such as hematological analyzers. A clinical hematology laboratory is crucial in giving various valuable prognostic markers such as lymphopenia, neutrophilia, leukocytosis, and thrombocytopenia, all of which are typical findings in SARS-CoV-2 virus patients. Furthermore, patients with COVID-19 and sickle cell disease (SCD) were at a higher risk of hospitalization, pneumonia, and discomfort. Because persons with SCD were more likely to get additional infections, it was critical to monitor their health, which had a significant impact on the market. As a result of the increased importance of hematological testing in COVID-19 infected patients, the demand for hematology products and reagents is expected to rise. The pandemic, on the other hand, is disrupting the supply chain. Thus, the COVID-19 pandemic has had an impact on the market. However, the situation is expected to improve steadily over the forecast period.

Segment Analysis

Hematology Analyzers segment is expected to hold the largest market share in hematology market.

The hematology analyzers segment accounted for the largest market share in 2021. The segment is beneficial because these instruments are used to execute tests on blood samples. They are used to perform tests such as a complete blood count, which includes a count of red blood cells, white blood cells, platelets, and hemoglobin, and characterize blood cells to diagnose a disease condition. Moreover, product launches and technological advancements in the analyzers are the other factors to boost the market in the forecast period. For instance, HORIBA Medical introduced new products in its Yumizen H500 & H550 hematology product family in July 2022, including compact benchtop hematology analyzers with improved performance, additional capabilities, and expanded benefits. These products are intended to provide a brief and complete hematological report with a throughput of 60 tests/hour, 40 tubes autonomy with continuous loading, an urgent manual mode, and the ability to run samples via multi-analysis modes and sampling. Therefore, it has increased the demand for hematology analyzers.

Geographical Analysis

North America region holds the largest market share in the global hematology market

In 2021, North American Hematology accounted for the highest revenue share in the global market. The increasing prevalence of blood cancers, technological advancements in the analyzers, well-established infrastructure, product launches and collaborations by the key market players and FDA approvals in the region are the factors to drive the market growth in the forecast period. For instance, according to the Leukemia & Lymphoma Society, in 2021, an estimated 186,400 persons in the United States will be diagnosed with leukemia, lymphoma, or myeloma. Moreover, new cases of leukemia, lymphoma and myeloma are expected to account for 9.8 percent of the estimated 1,898,160 new cancer cases diagnosed in the US in 2021. Therefore, it has increased the demand for hematology analyzers. Moreover, On April 20, 2022, Sysmex America, Inc. received the United States Food and Drug Administration's 510(k) approval for Sysmex XN-10 Automated Hematology Analyzer. Thus, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the hematology market are Abbott Laboratories, Sysmex Corporation, Danaher Corporation, Siemens Healthcare, Sigma Aldrich Corporation, Drucker Diagnostics, Bio-Rad Laboratories, Roche Diagnostics, Mindray Medical International Ltd, Horiba Ltd.

Abbott Laboratories:

Overview:

Abbott Laboratories is an American multinational medical device and healthcare company that explores, develops, manufactures, and sells a broad and diversified line of healthcare products. It split off its research-based pharmaceuticals business into AbbVie in 2013. It benefits through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Others. Its well-known products across the medical devices, diagnostics, and nutrition divisions are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. One hundred nine thousand colleagues serve people in more than 160 countries.

Product Portfolio:

CELL-DYN Sapphire: CELL-DYN Sapphire's trusted analysis helps focus on the most important part of work: supporting excellent patient care. Behind every sample is an anxious patient or family awaiting a decision. It helps achieve accurate first pass results because there is little room for error, whether the decision contributes to a diagnosis, change in therapy, or transfusion. By helping reduce sample reruns, reflex testing, turnaround time, and smear review rates, the CELL-DYN Sapphire maximizes productivity and lowers laboratory costs. With the ability to perform 105 CBCs per hour, the consumer can process a full range of normal to abnormal patient samples in the laboratory.

The global hematology market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements in hematological analyzers are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Regulatory and reimbursement concerns are expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Hematology Analyzers*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Flow Cytometers
  • 7.4. Coagulation Analyzers
  • 7.5. Slide Stainers
  • 7.6. Centrifuges
  • 7.7. Hemoglobinometers
  • 7.8. Others

8. By Reagent Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 8.1.2. Market Attractiveness Index, By Reagent Type Segment
  • 8.2. Coagulation Reagents*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Flow Cytometery Reagents
  • 8.4. Immuno-hematology Reagents
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Drug Testing*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Auto-immune Diseases
  • 9.4. Cancer
  • 9.5. Diabetes Mellitus
  • 9.6. Infectious Diseases
  • 9.7. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinical Testing Institutes
  • 10.4. Patient Self-testing
  • 10.5. Diagnostic Centers
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Hematology Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abbott Laboratories*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Sysmex Corporation
  • 13.3. Danaher Corporation
  • 13.4. Siemens Healthcare
  • 13.5. Sigma Aldrich Corporation
  • 13.6. Drucker Diagnostics
  • 13.7. Bio-Rad Laboratories
  • 13.8. Roche Diagnostics
  • 13.9. Mindray Medical International Ltd
  • 13.10. Horiba Ltd

LIST NOT EXHAUSTIVE

14. Global Hematology Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us